162 related articles for article (PubMed ID: 25354788)
21. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation.
Jain A; Chasoo G; Singh SK; Saxena AK; Jain SK
J Microencapsul; 2011; 28(1):21-8. PubMed ID: 21171813
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
Patel BK; Parikh RH; Patel N
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
[TBL] [Abstract][Full Text] [Related]
24. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
25. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
26. Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium.
Sundaram S; Roy SK; Ambati BK; Kompella UB
FASEB J; 2009 Nov; 23(11):3752-65. PubMed ID: 19608628
[TBL] [Abstract][Full Text] [Related]
27. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Lin PI; Wang CC
Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
[TBL] [Abstract][Full Text] [Related]
29.
Cayero-Otero MD; Gomes MJ; Martins C; Álvarez-Fuentes J; Fernández-Arévalo M; Sarmento B; Martín-Banderas L
Expert Opin Drug Deliv; 2019 Dec; 16(12):1413-1427. PubMed ID: 31694417
[No Abstract] [Full Text] [Related]
30. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
31. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Girotra P; Singh SK; Kumar G
Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
[TBL] [Abstract][Full Text] [Related]
32. Concepts and practices used to develop functional PLGA-based nanoparticulate systems.
Sah H; Thoma LA; Desu HR; Sah E; Wood GC
Int J Nanomedicine; 2013; 8():747-65. PubMed ID: 23459088
[TBL] [Abstract][Full Text] [Related]
33. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles.
Avgoustakis K; Beletsi A; Panagi Z; Klepetsanis P; Livaniou E; Evangelatos G; Ithakissios DS
Int J Pharm; 2003 Jun; 259(1-2):115-27. PubMed ID: 12787641
[TBL] [Abstract][Full Text] [Related]
34. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
35. Methyl trypsin loaded poly(D,L-lactide-coglycolide) nanoparticles for contact lens care.
Jimenez N; Galan J; Vallet A; Egea MA; Garcia ML
J Pharm Sci; 2010 Mar; 99(3):1414-26. PubMed ID: 19774659
[TBL] [Abstract][Full Text] [Related]
36. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
39. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
40. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.
Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]